The project is expected to increase the production area, where inhalers, insulin pens, lancing devices and various diagnostic systems are manufactured, by an additional 3,500 m².
Gerresheimer CEO Uwe Rohrhoff said the company will be investing in additional production capacity, the optimization of production and logistics operations and reduce the energy consumption to achieve further growth.
"The Czech plant in Horsovsky Tyn is developing very positively," Rohrhoff added.
The modern warehouse for semi-finished products is being enlarged and equipped with clean room technology and the tool service is being expanded to optimize the production, service and logistics processes in existing and future production operations.
The installation of an integrated compressed air energy system will optimize the plant’s energy consumption. Construction work will begin in 2012 and is scheduled to conclude in 2013, according to the company.